Skip to main content
  • Why CDL
  • Who We Serve
    • Overview
    • Cardiologists
    • C-Level Executives
    • Practice Administrators
    • Technologists
  • Solutions
    • Overview
    • Cardiac PET
    • Coronary Flow Reserve
    • CardioNavix
    • Laurel Healthcare Solutions
    • Cardiac SPECT
    • Staffing
  • CV ASC Labs
  • About
    • Our Story
  • Careers
  • Pet Resources
    • What is PET
    • What Makes PET Different
    • What To Expect
    • Your Cardiac PET Scan
  • Blog
  • Webinars
  • Events
  • Contact
CDL Nuclear Technologies
  • Blog
  • Webinars
  • Events
  • Contact
  • Clients
  • Login below or Request Access to the Clients Portal.

    Lost your password?
    Register
    Forgotten Password
    Cancel

    Register For This Site

    A password will be e-mailed to you.

  • Employees
  • Login below or Request Access to the Employees Portal.

    Lost your password?
    Register
    Forgotten Password
    Cancel

    Register For This Site

    A password will be e-mailed to you.

  • Why CDL
  • Who We Serve
    • Overview
    • Cardiologists
    • C-Level Executives
    • Practice Administrators
    • Technologists
  • Solutions
    • Overview
    • Cardiac PET
    • Coronary Flow Reserve
    • CardioNavix
    • Laurel Healthcare Solutions
    • Cardiac SPECT
    • Staffing
  • CV ASC Labs
  • About
    • Our Story
  • Careers
  • Pet Resources
    • What is PET
    • What Makes PET Different
    • What To Expect
    • Your Cardiac PET Scan

Blog

Abdominal Obesity

Posted on May 5, 2021 by CDL Nuclear

Abdominal Obesity

The global obesity epidemic is well established, with most countries experiencing a four-decade increase in obesity prevalence. Since 1975, global obesity has nearly tripled. Over 1.9 billion adults aged 18 years and older were overweight in 2016; 650 million of these adults were obese.

Obesity is directly associated with cardiovascular risk factors such as dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. Obesity also contributes to the development and mortality of cardiovascular disease, regardless of other cardiovascular risk factors. 

Recent data emphasize the importance of abdominal obesity, as measured by waist circumference, as a risk factor for cardiovascular disease independent of body mass index. The relationship between abdominal fat and cardiovascular outcomes demonstrates unequivocally that visceral fat is a health hazard. Because abdominal obesity has such a strong risk-inducing effect, even in people who are overweight or obese based on their BMI, low levels of fat tissue around their midsection and organs may indicate lower cardiovascular disease risks.

According to the US Centers for Disease Control and Prevention, non-pregnant women with waist sizes greater than 35 inches and men with waist sizes greater than 40 inches are at an increased risk.

Experts evaluated research on managing and treating obesity, particularly abdominal obesity, for this statement. According to the writing group, calorie restriction can help reduce abdominal fat, and aerobic exercise is the most beneficial physical activity for reducing abdominal obesity. Their analysis discovered that adhering to current recommendations of 150 minutes of physical activity per week may be sufficient to reduce abdominal fat without requiring longer activity times. Exercise, or a combination of dietary changes and physical activity, has been shown to reduce abdominal obesity in some cases, even in the absence of weight loss.

Additional Reading:

Waist size predicts heart attacks better than BMI, especially in women

Share on:

Categories

  • All Posts
  • Uncategorized

Archives

Tags

  • heart health
  • pet/ct
  • cardiac pet imaging
  • COVID-19
  • heart disease
  • hypertension
  • stress
  • events
  • webinar
  • heart attack
  • cardiology
  • news
  • healthy eating
  • exercise
  • thyroid
  • carotid artery disease
  • women's health
  • stroke
  • calcium scoring
  • sleep

Phone: 724-933-5570

Email: info@cdlnuclear.com

Connect
  • LinkedIn

DISCLAIMER: This website does not provide medical advice.
© 2023 CDL Nuclear Technologies | Your Partner in PET